nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—Digestion impaired—Fludarabine—lymphatic system cancer	0.0728	0.0728	CcSEcCtD
Benzphetamine—Cardiomyopathy—Mitoxantrone—lymphatic system cancer	0.0565	0.0565	CcSEcCtD
Benzphetamine—Sweating—Teniposide—lymphatic system cancer	0.0297	0.0297	CcSEcCtD
Benzphetamine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0255	0.0255	CcSEcCtD
Benzphetamine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Benzphetamine—Agitation—Teniposide—lymphatic system cancer	0.0222	0.0222	CcSEcCtD
Benzphetamine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0197	0.0197	CcSEcCtD
Benzphetamine—Agitation—Fludarabine—lymphatic system cancer	0.0195	0.0195	CcSEcCtD
Benzphetamine—Tachycardia—Teniposide—lymphatic system cancer	0.0193	0.0193	CcSEcCtD
Benzphetamine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Benzphetamine—Anorexia—Teniposide—lymphatic system cancer	0.0188	0.0188	CcSEcCtD
Benzphetamine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0183	0.0183	CcSEcCtD
Benzphetamine—Decreased appetite—Teniposide—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Benzphetamine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Benzphetamine—Anorexia—Fludarabine—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Benzphetamine—Sweating—Vincristine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Benzphetamine—Nausea—Mechlorethamine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Benzphetamine—Urticaria—Teniposide—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Benzphetamine—Sweating—Mitoxantrone—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Benzphetamine—Dyspepsia—Fludarabine—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Benzphetamine—Decreased appetite—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.015	0.015	CcSEcCtD
Benzphetamine—Hypersensitivity—Teniposide—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Benzphetamine—Diarrhoea—Teniposide—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Benzphetamine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Benzphetamine—Tremor—Carmustine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Benzphetamine—Agitation—Carmustine—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Benzphetamine—Headache—Teniposide—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Benzphetamine—Anorexia—Bleomycin—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Benzphetamine—Agitation—Vincristine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Benzphetamine—Diarrhoea—Fludarabine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Benzphetamine—Nausea—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Benzphetamine—Decreased appetite—Bleomycin—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Benzphetamine—Headache—Fludarabine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Benzphetamine—Tachycardia—Carmustine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Benzphetamine—Anorexia—Carmustine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Benzphetamine—Nausea—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Benzphetamine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Benzphetamine—Urticaria—Bleomycin—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Benzphetamine—Anorexia—Vincristine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Benzphetamine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Benzphetamine—Insomnia—Carmustine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Benzphetamine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00998	0.00998	CcSEcCtD
Benzphetamine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00984	0.00984	CcSEcCtD
Benzphetamine—Decreased appetite—Carmustine—lymphatic system cancer	0.00965	0.00965	CcSEcCtD
Benzphetamine—Insomnia—Vincristine—lymphatic system cancer	0.00959	0.00959	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00959	0.00959	CcSEcCtD
Benzphetamine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00937	0.00937	CcSEcCtD
Benzphetamine—Decreased appetite—Vincristine—lymphatic system cancer	0.00922	0.00922	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00915	0.00915	CcSEcCtD
Benzphetamine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00909	0.00909	CcSEcCtD
Benzphetamine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00897	0.00897	CcSEcCtD
Benzphetamine—Urticaria—Mitoxantrone—lymphatic system cancer	0.0082	0.0082	CcSEcCtD
Benzphetamine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00818	0.00818	CcSEcCtD
Benzphetamine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00781	0.00781	CcSEcCtD
Benzphetamine—Sweating—Methotrexate—lymphatic system cancer	0.00773	0.00773	CcSEcCtD
Benzphetamine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Benzphetamine—Diarrhoea—Carmustine—lymphatic system cancer	0.0076	0.0076	CcSEcCtD
Benzphetamine—Nausea—Bleomycin—lymphatic system cancer	0.00756	0.00756	CcSEcCtD
Benzphetamine—Dizziness—Carmustine—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Benzphetamine—Diarrhoea—Vincristine—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Benzphetamine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Benzphetamine—Dizziness—Vincristine—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Benzphetamine—Headache—Carmustine—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Benzphetamine—Headache—Vincristine—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Benzphetamine—Nausea—Carmustine—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Benzphetamine—Headache—Mitoxantrone—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Benzphetamine—Nausea—Vincristine—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Benzphetamine—Nausea—Mitoxantrone—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Benzphetamine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Benzphetamine—Anorexia—Methotrexate—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Benzphetamine—Insomnia—Methotrexate—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Benzphetamine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Benzphetamine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Benzphetamine—Urticaria—Methotrexate—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Benzphetamine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Benzphetamine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Benzphetamine—Dizziness—Methotrexate—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Benzphetamine—Headache—Methotrexate—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Benzphetamine—Nausea—Methotrexate—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
